SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Lepidico Limited (LPDNF) , forward earnings yield 909.09%.
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
- Forward P/E 0.1
Overall SharesGrow Score: 43/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — LPDNF
Valuation Multiples
P/E (TTM)0.0
Forward P/E0.1
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.00
Forward EPS (Est.)$0.01
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Forward Earnings Yield909.09%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$0.00 |
$9.09K |
$-1.04M |
-11485.1% |
| 2016 |
$0.00 |
$115.84K |
$-2.26M |
-1953.6% |
| 2017 |
$0.00 |
$126.55K |
$-5.36M |
-4233.2% |
| 2018 |
$0.00 |
$61.17K |
$-7.22M |
-11803.2% |
| 2019 |
$0.00 |
$0.00 |
$-5.11M |
- |
| 2020 |
$0.00 |
$0.00 |
$-10.12M |
- |
| 2021 |
$0.00 |
$4.08M |
$282.56K |
6.9% |
| 2022 |
$0.00 |
$0.00 |
$-7.94M |
- |
| 2023 |
$0.00 |
$0.00 |
$-3.6M |
- |
| 2024 |
$0.00 |
$0.00 |
$-6.44M |
- |
